Modeling and simulation of adherence: approaches and applications in therapeutics
- PMID: 16353919
- PMCID: PMC2750977
- DOI: 10.1208/aapsj070240
Modeling and simulation of adherence: approaches and applications in therapeutics
Abstract
Partial adherence with a prescribed or randomly assigned dose gives rise to unintended variability in actual drug exposure in clinical practice and during clinical trials. There are tremendous costs associated with incomplete and/or improper drug intake-to both individual patients and society as a whole. Methodology for quantifying the relation between adherence, exposure and drug response is an area of active research. Modeling and statistical approaches have been useful in evaluating the impact of adherence on therapeutics and in addressing the challenges of confounding and measurement error which arise in this context. This paper reviews quantitative approaches to using adherence information in improving therapeutics. It draws heavily on applications in the area of HIV pharmacology.
References
-
- Vrijens B, Tousset E, Gaillard P, Metry J, Urquhart J. Major features of dose omissions in 87 ambulatory drug trials. Clin Pharmacol Ther. 2005;77:99–99.
-
- Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm. 1991;48:1978–1988. - PubMed
-
- Cramer JA, Spilker B, editors. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press Ltd; 1991.
-
- Didlake RH, Dreyfus K, Kermanet RH, et al. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc. 1988;20(suppl 3):63–69. - PubMed
-
- Kastrissios H, Blaschke TF. Therapeutic implications of nonadherence with antiretroviral drug regimens. HIV. 1998;8:24–28.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
